Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression

Current chemotherapy regimens have certain limitations in improving the survival rates of patients with advanced ovarian cancer. Hepatocyte growth factor (HGF) is important in ovarian cancer cell migration and invasion. This study assessed the effects of YYB-101, a humanized monoclonal anti-HGF anti...

Descrición completa

Detalles Bibliográficos

Principais autores:	Hyun Jung Kim, Sukmook Lee, Yong-Seok Oh, Ha Kyun Chang, Young Sang Kim, Sung Hee Hong, Jung Yong Kim, Young-Whan Park, Song-Jae Lee, Seong-Won Song, Jung Ju Kim, Kyun Heo
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2019-07-01
Series:	Frontiers in Oncology
Assuntos:	HGF humanized monoclonal antibody ovarian cancer metastasis YYB-101
Acceso en liña:	https://www.frontiersin.org/article/10.3389/fonc.2019.00571/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!